搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
最佳匹配
最新
资讯
3 天
Liminatus Pharma任命Philip Lemons和Richard Baek为董事会成员
Liminatus Pharma, Inc. (NASDAQ: LIMN ),一家市值1.73亿美元的制药公司,周四宣布其董事会已扩大至六名成员,任命Philip Lemons和Richard Baek为董事,即刻生效。根据 InvestingPro 数据,该公司面临一些财务挑战,财务健康状况评分较弱,且在过去十二个月内未实现盈利。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
SCOTUS allows mass firings
More than 20 states sue
Fire at assisted living home
Hidden in cake boxes
Historic lodge destroyed
Elway won't be charged
Bear attacks WI woman
1st look at new Harry Potter
To unveil $70 billion in AI
Wins celebrity golf event
Warfighting drills in AU
Nicotine poisoning rises?
Flies to $217M globally
Seeks 8th presidential term
UKR to get Patriot missiles?
No. 1 pick in MLB draft
To end Abu Dhabi flights
Club World Cup victory
Elmo’s X account hacked
Berlin doctor goes on trial
Approves blue food dye
To start using Grok
65 yrs for killing girlfriend
Kenvue's CEO quits
Coach Bridgewater suspended
Faces trial over fatal crash
Asks to review renovation
Bitcoin soars past $120K
Changes remote work policy
Southend plane crash
反馈